Home / Germany / Amneal Pharmaceuticals, INC.
Amneal Pharmaceuticals, INC.
Short position disclosed on June 13, 2018.
0.58% of the capital sold short
1 disclosing funds
3 disclosures on record
US03168L1052 ISIN code
Evolution of the disclosed total
0%0.2%0.4%0.6%
Oct 2025Jan 2026Apr 2026Jul 2026
May 23, 2018 today
Open positions
| Fund | Twelve months | % of capital | Over the year | Since |
|---|---|---|---|---|
| Point72 Asset Management, L.P. | 0.58% | unchanged | June 13, 2018 |
On the other side: the funds that hold Amneal Pharmaceuticals, INC. Titelia
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| June 13, 2018 | Point72 Asset Management, L.P. | 0.58% | still open |
| May 25, 2018 | POINT72 Asset Management, L.P. | 0.63% | still open |
| May 23, 2018 | POINT72 Asset Management, L.P. | 0.54% | still open |
Other companies sold short in Germany
- TUI AG 9.00% of the capital sold short
- AUTO1 Group SE 7.29% of the capital sold short
- HelloFresh SE 7.00% of the capital sold short
- Hugo Boss AG 6.18% of the capital sold short
- Gerresheimer AG 5.98% of the capital sold short
- Cancom SE 5.46% of the capital sold short
- PVA TePla AG 5.30% of the capital sold short
- Zalando SE 5.22% of the capital sold short
- LANXESS Aktiengesellschaft 5.11% of the capital sold short
- Tamboran Resources Corp. 4.96% of the capital sold short
- Kontron AG 4.94% of the capital sold short
- Aeluma, INC. 4.82% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Amneal Pharmaceuticals, INC., source Bundesanzeiger, data as at June 13, 2018, https://www.quivad.com/action/amneal-pharmaceuticals-inc